DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED

Ajouter à une liste

Communiqués Dawnrays Pharmaceutical (Holdings) Limited

Actions

2348

KYG2687M1006

Produits pharmaceutiques

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:13 11/08/2026			Varia. 5j.	Varia. 1 janv.
0,9900 ^HKD	0,00%		-2,94%	-18,85%

29/05	Dawnrays Pharmaceutical (Holdings) Limited annonce que sa filiale, Fujian Dawnrays Pharmaceutical Co., Ltd., a obtenu l'autorisation de mise sur le marché pour le chlorhydrate de trazodone en comprimés de 50 mg et 100 mg	CI
22/05	Dawnrays Pharmaceutical (Holdings) Limited approuve le dividende final pour l'exercice clos le 31 décembre 2025	CI

Communiqués

20/04/21	Dawnrays Pharmaceutical : Form of proxy for use at the Annual General Meeting of the Company to be held on Friday, 28 May 2021 (or at any adjournment thereof)	PU
20/04/21	Dawnrays Pharmaceutical : PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING	PU
23/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
22/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
21/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
18/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
17/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
15/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
11/09/20	Dawnrays Pharmaceutical : Next Day Disclosure Return	PU
20/08/20	Dawnrays Pharmaceutical : SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2019 ANNUAL REPORT	PU
14/08/20	Dawnrays Pharmaceutical : DISCLOSEABLE TRANSACTION-CONSTRUCTION AGREEMENTS	PU
22/08/17	Dawnrays Pharmaceutical : Announcement of Interim Results for the six months ended 30 June 2017	PU
04/08/17	Dawnrays Pharmaceutical : CHANGE IN BOARD LOT SIZE	PU
30/03/12	Dawnrays Pharmaceuti : List of Directors and their Role and Function	PU
24/03/12	Dawnrays Pharmaceuti : Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2011, Net Profit after Tax Dropped 12.3% to RMB 146.31 Million, A Final Dividend of HK$ 0.068 per Share was Declared	PU
05/03/12	Dawnrays Pharmaceuti : Date of Board Meeting	PU
21/12/11	Dawnrays Pharmaceuti : Voluntary Announcement New Product Pharmaceutical Registration Approval	PU
23/08/11	Dawnrays Pharmaceuti : Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Espace mes listes

Palmarès

Suite du Palmarès

Palmarès

Suite du Palmarès

Devises / Forex

Matières Premières

Cryptomonnaies

Taux d'Intérêts

Bourse
Actions
Action 2348
Actualités Dawnrays Pharmaceutical (Holdings) Limited
Communiqués

Dès maintenant, trouvez facilement les meilleurs investissements de demain !